Cargando…
The Utility of a Rapid Review Evaluation Process to a National HTA Agency
BACKGROUND AND OBJECTIVE: In Ireland, similar to other jurisdictions, health technology assessment (HTA) is used to inform the health payer’s drug reimbursement decisions. These HTAs are conducted by the National Centre for Pharmacoeconomics (NCPE). In 2009, the NCPE introduced the Rapid Review proc...
Autores principales: | Varley, Áine, Tilson, Lesley, Fogarty, Emer, McCullagh, Laura, Barry, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795027/ https://www.ncbi.nlm.nih.gov/pubmed/34635994 http://dx.doi.org/10.1007/s40273-021-01093-8 |
Ejemplares similares
-
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
por: Lamrock, Felicity, et al.
Publicado: (2020) -
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017
por: Usher, Cara, et al.
Publicado: (2019) -
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
por: Leahy, Joy, et al.
Publicado: (2020) -
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021) -
HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)